We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.79%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$30M
Cap. Flow
-$33.2M
Cap. Flow %
-21.62%
Top 10 Hldgs %
41.01%
Holding
85
New
17
Increased
10
Reduced
29
Closed
24

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$5.56M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.98M
3
AKCA
Akcea Therapeutics Inc
AKCA
+$1.96M
4
PBYI icon
Puma Biotechnology
PBYI
+$1.96M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$1.93M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$5.61M
2
AET
Aetna Inc
AET
+$4.53M
3
LLY icon
Eli Lilly
LLY
+$3.42M
4
GKOS icon
Glaukos
GKOS
+$3.3M
5
XLRN
Acceleron Pharma
XLRN
+$2.61M

Sector Composition

Rank Sector Weight
1 Healthcare 81.64%
2 Energy 0.6%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CORI
51
DELISTED
Corium International, Inc.
CORI
$865K 0.56%
90,000
-35,000
-28% -$373K
VYGR icon
52
Voyager Therapeutics
VYGR
$195M
$830K 0.54%
50,000
+25,000
+100% +$429K
MRNS
53
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$816K 0.53%
25,000
-18,750
-43% -$505K
AKAO
54
DELISTED
Achaogen Inc
AKAO
$806K 0.52%
75,000
+45,000
+150% +$565K
ADVM
55
DELISTED
Adverum Biotechnologies
ADVM
$700K 0.46%
+20,000
New +$658K
OMED
56
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$615K 0.4%
150,000
-200,000
-57% -$870K
CCXI
57
DELISTED
ChemoCentryx, Inc.
CCXI
$595K 0.39%
100,000
-175,000
-64% -$1.2M
SCYX icon
58
SCYNEXIS
SCYX
$48.7M
$580K 0.38%
3,125
– –
WMGI
59
DELISTED
Wright Medical Group Inc
WMGI
$444K 0.29%
+20,000
New +$493K
LUMO
60
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$406K 0.26%
+5,556
New +$460K
ASXC
61
DELISTED
Asensus Surgical, Inc.
ASXC
$241K 0.16%
+9,615
New +$296K
ADAP
62
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-25,000
Closed -$205K
ASND icon
63
Ascendis Pharma A/S
ASND
$16.7B
– –
-30,000
Closed -$1.09M
CAH icon
64
Cardinal Health
CAH
$56.8B
– –
-30,000
Closed -$2.01M
EXEL icon
65
PUT
Exelixis
EXEL
$13B
– –
-25,000
Closed -$606K
KYNB
66
Kyntra Bio
KYNB
$28.9M
– –
-1,600
Closed -$2.15M
FOLD
67
DELISTED
Amicus Therapeutics
FOLD
– –
-60,000
Closed -$905K
GKOS icon
68
Glaukos
GKOS
$10.7B
– –
-100,000
Closed -$3.3M
INCY icon
69
CALL
Incyte
INCY
$24.4B
– –
-7,500
Closed -$876K
INSM icon
70
Insmed
INSM
$29.3B
– –
-50,000
Closed -$1.56M
KURA icon
71
Kura Oncology
KURA
$866M
– –
-90,000
Closed -$1.35M
LLY icon
72
Eli Lilly
LLY
$1.08T
– –
-40,000
Closed -$3.42M
PTCT icon
73
CALL
PTC Therapeutics
PTCT
$6.11B
– –
-25,000
Closed -$500K
TDOC icon
74
Teladoc Health
TDOC
$1.28B
– –
-35,000
Closed -$1.16M
CBAY
75
DELISTED
Cymabay Therapeutics
CBAY
– –
-250,000
Closed -$2.02M
1 2
3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2017 Portfolio in Review

As of Q4 2017, Iguana Healthcare Management held 85 positions worth $154M, down 16% from $184M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Iguana Healthcare Management withdrew a net $33.2M in Q4 2017, closing 24 positions and reducing 29 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $5.61M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 77% a quarter earlier, followed by Energy and Financials.

Against the trend, Iguana Healthcare Management opened a new position in Humana worth $5.58M.

  • Iguana Healthcare Management's largest Q4 2017 buy was Humana: 22,500 shares worth $5.58M.
  • Iguana Healthcare Management added most to Ionis Pharmaceuticals in Q4 2017, an estimated $1.37M increase.
  • Iguana Healthcare Management's biggest Q4 2017 reduction was Boston Scientific, cutting an estimated $2.07M.
  • Iguana Healthcare Management fully exited Alexion Pharmaceuticals in Q4 2017, selling an estimated $5.61M.
  • Iguana Healthcare Management's ten largest holdings make up 41% of its $154M portfolio in Q4 2017.
  • Iguana Healthcare Management opened 17 new positions and closed 24 in Q4 2017.
  • Iguana Healthcare Management's portfolio value fell 16% quarter-over-quarter to $154M.

Based on Iguana Healthcare Management's 13F filing for Q4 2017, filed 14 Feb 2018.